Suven Life Sciences Ltd’s net profit decreased 48 per cent at ₹17 crore in the fourth quarter ended March 31, compared to ₹32.4 crore in the corresponding quarter of previous year.
The total revenue of the Hyderabad-based company also took a hit, decreasing by 13 per cent to ₹114.5 crore (₹132 crore).
For the full year ended March 31, its profit declined by 25 per cent to ₹109 crore (₹144 crore) on a revenue of ₹529 crore (₹513 crore), according to a release.
The board has approved a dividend of ₹0.60 per share subject to the approval of shareholders.
The company’s scrip fell 6.80 per cent to end at ₹267.35 on the Bombay Stock Exchange on Wednesday.